Benzothiophene hydroxamic acid derivatives

Details for Australian Patent Application No. 2006240248 (hide)

Owner Merck & Co., Inc.

Inventors Hubbs, Jed Lee; Miller, Thomas; Wilson, Kevin; Kattar, Sam; Stanton, Matthew; Siliphaivanh, Phieng; Methot, Joey; Witter, David J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006240248

PCT Pub. Number WO2006/115835

Priority 60/673,121 20.04.05 US

Filing date 14 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 333/56 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/115835 Priority application(s): WO2006/115835

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006240252-Composition suitable for high gloss blown film and films made therefrom

2006240247-Angiotensin II receptor antagonists